Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 183.35 0.00 (0.00%) | NSE 183.20 -0.14 (-0.08%) | Trade | Add

BSE Live

Oct 29, 11:34

183.35 0.00 (0.00%)

Volume

AVERAGE VOLUME

5-Day

52,654

10-Day

59,413

30-Day

93,116

46,282

Prev. Close

183.35
Open Price

180.95

Bid Price (Qty.)
183.15 (157)
Offer Price (Qty.)
183.35 (527)

NSE Live

Oct 29, 11:34

183.20 -0.14 (-0.08%)

Volume

AVERAGE VOLUME

5-Day

673,825

10-Day

932,049

30-Day

1,207,765

325,491

Prev. Close

183.34
Open Price

184.70

Bid Price (Qty.)
183.20 (209)
Offer Price (Qty.)
183.29 (1)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Marksans Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	8.40	6.92	6.41	4.51	5.76
Diluted EPS (Rs.)	8.40	6.92	6.41	4.51	5.76
Cash EPS (Rs.)	10.28	8.59	7.00	5.66	6.71
Book Value [ExclRevalReserve]/Share (Rs.)	54.44	46.03	38.95	29.88	22.12
Book Value [InclRevalReserve]/Share (Rs.)	54.44	46.03	38.95	29.88	22.12
Revenue from Operations/Share (Rs.)	57.88	48.05	40.87	36.42	33.62
PBDIT/Share (Rs.)	13.22	11.23	8.80	7.35	8.46
PBIT/Share (Rs.)	11.38	9.59	7.65	6.25	7.58
PBT/Share (Rs.)	11.12	9.35	7.45	6.05	7.38
Net Profit/Share (Rs.)	8.44	6.95	5.85	4.56	5.83
NP After MI And SOA / Share (Rs.)	8.40	6.92	5.88	4.56	5.83
Profitability Ratios
PBDIT Margin (%)	22.83	23.37	21.52	20.17	25.16
PBIT Margin (%)	19.65	19.96	18.72	17.16	22.53
PBT Margin (%)	19.21	19.45	18.23	16.60	21.95
Net Profit Margin (%)	14.58	14.46	14.32	12.53	17.33
NP After MI And SOA Margin (%)	14.51	14.40	14.37	12.53	17.33
Return on Networth/Equity (%)	15.42	15.19	15.25	15.53	26.90
Return on Capital Employed (%)	18.66	18.97	18.75	19.93	33.35
Return on Assets (%)	11.74	11.70	12.15	11.39	19.42
Total Debt/Equity (X)	0.01	0.01	0.02	0.03	0.02
Asset Turnover Ratio (%)	0.89	0.89	0.97	1.04	112.04
Liquidity Ratios
Current Ratio (X)	4.62	4.78	4.91	3.37	3.02
Quick Ratio (X)	2.85	3.19	3.49	2.18	1.67
Inventory Turnover Ratio (X)	3.58	1.21	1.35	1.30	3.40
Dividend Payout Ratio (NP) (%)	7.14	7.22	3.81	5.47	1.71
Dividend Payout Ratio (CP) (%)	5.86	5.84	3.19	4.41	1.49
Earnings Retention Ratio (%)	92.86	92.78	96.19	94.53	98.29
Cash Earnings Retention Ratio (%)	94.14	94.16	96.81	95.59	98.51
Coverage Ratios
Interest Coverage Ratios (%)	51.37	45.43	43.67	35.61	38.83
Interest Coverage Ratios (Post Tax) (%)	51.37	45.43	43.67	35.61	38.83
Valuation Ratios
Enterprise Value (Cr.)	9,417.36	6,244.01	2,540.86	1,577.14	1,869.83
EV/Net Operating Revenue (X)	3.59	2.87	1.37	1.06	1.36
EV/EBITDA (X)	15.72	12.27	6.37	5.24	5.40
MarketCap/Net Operating Revenue (X)	3.84	3.15	1.72	1.25	1.49
Retention Ratios (%)	92.85	92.77	96.18	94.52	98.28
Price/BV (X)	4.08	3.33	1.83	1.55	2.31
Price/Net Operating Revenue	3.84	3.15	1.72	1.25	1.49
Earnings Yield	0.04	0.05	0.08	0.10	0.12